Zweers M

No ORCID on file · 1 paper in corpus
observational 2026
JAAD international ·doi:10.1016/j.jdin.2026.09.010

BackgroundJanus kinase inhibitors baricitinib and ritlecitinib are approved for the treatment of severe alopecia areata (AA). However, prospective real-world data on effectiveness, disease burden, and tolerability are limited.ObjectiveTo ev…